AML1-Evi1基因致急性髓系白血病的分子机制研究（斑马鱼模型）

项目名称： AML1-Evi1基因致急性髓系白血病的分子机制研究（斑马鱼模型）

项目编号： No.81470312

项目类型： 面上项目

立项/批准年度： 2015

项目学科： 医药、卫生

项目作者： 陈芳源

作者单位： 上海交通大学

项目金额： 70万元

中文摘要： 急性髓系白血病发生与染色体及基因异常有关，AML1-Evi1融合基因多见急性髓细胞白血病且预后极差。该基因使造血干/祖细胞分化不良或受阻的机制及其与单基因的作用差异仍未明确。本课题利用斑马鱼发育与疾病模式生物体的独特优势，在前期已建立Tg(AML1-Evi1:EGFP)斑马鱼研究工作基础上，再建Tg(AML1:EGFP)和Tg(Evi1:EGFP)斑马鱼模型，通过转录组测序，原位杂交，活体RNA干扰等技术进行功能比对，深入研究AML1-Evi1的功能及AML1-Evi1融合基因独特的致白血病通路和靶基因，并进行活体高通量药物筛选，识别特异性针对AML1-Evi1靶基因的先导候选药物。最后在转染AML1-Evi1质粒的脐带血CD34+细胞、AML1-Evi1阳性患者原代细胞中进行体外验证，以明确抑制AML1-Evi1白血病靶基因治疗在AML中的可行性，为靶向治疗提供新的思路，具有开创性意义。

中文关键词： AML1-Evi1；急性髓系白血病；分子机制；斑马鱼；转基因

英文摘要： Acute myeloid leukemia is related to abnormal chromosome and genetic mutations. The AML1-Evi1 fusion gene is seen more at in acute myeloid leukemia and the prognosis is poor. Although AML1 and Evi1, as a function of a single gene, have been reported in the literature, how dose the fusion gene make the hematopoietic stem cells and progenitor cells with poor differentiation or hindered mechanism has been still unclear. Effect of differences between AML1-Evi1 and single gene of AML1 and Evi1 is not clear. The subject make use of the unique advantages of zebrafish with development and disease model organism, we have established stable transgenic line of Tg(AML1-Evi1:EGFP) zebrafish model in the early stage based on the research work, and reestablished stable transgenic line of Tg (AML1:EGFP) and Tg (Evi1:EGFP) zebrafish model. Through transcriptome sequencing, whole-mount situ hybridization, RNA interference technology in vivo and other technologies, further study of the function of AML1-Evi1 and illustrate the AML1-Evi1 fusion gene induced uniquely the leukemia mechanism and pathway. Ultimately, basis on the above research, high throughout drug screening will be carried out on this AML1-Evi1 zebrafish model in vivo. Guiding drug candidate will be identified for specific target genes of AML1-Evi1. Finally, the candidate drugs will be proved in the umbilical cord blood CD34+ cells transfected with AML1-Evi1 plasmid and patients' leukemia cells in vitro, in order to clarify inhibition of AML1-Evi1 target gene treatment feasibility in AML. The applicant has rich experience in leukemia drug resistance research and transgenic zebrafish technology It is expected that the result of this research can provide a new method for targeted therapy and have groundbreaking significance.

英文关键词： AML1-Evi1;Acute myeloid leukemia;molecular mechanisms;zebrafish;transgene